Summary by Moomoo AI
Hangzhou Kaiming Medical Equipment Co., Ltd. (“Kai Ming Medical”) announces unaudited consolidated results for the year ended December 31, 2023. The report showed that the company's revenue reached RMB 491,373 million, an increase of 20.9% over the same period last year; gross profit of RMB 389,205 million, an increase of 24.0%. Despite the increase in revenue and gross profit, the company's loss for the year amounted to RMB 746,178 million, down 33.5% from last year. The owners of the parent company accounted for a loss of RMB720,876 million and a loss of RMB1.65 per share. The company's R&D cost is RMB 524,915 million, which is close to last year. During the reporting period, the company did not issue a final dividend and continued to suspend trading on the exchange.